IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson Universitymonoclonal_antibodyPhase 1/2Dormant
B
56/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 81/ 100
Competitive context
17 Active assets in the Adenocarcinoma of the Prostate cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Docetaxel Instituto do Cancer do Estado de São Paulo | Phase 3 | BBB |
PREDNISONE TABLETS Mayo Clinic | Phase 3 | BB |
(+)-VINCRISTINE Fred Hutchinson Cancer Center | Phase 3 | BB |
NILUTAMIDE SWOG Cancer Research Network | Phase 3 | BB |
Cyclophosphamide Beijing Biotech | Phase 2 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →